a b s t r a c tBackground and purpose: This study aimed to assess dose distributions for stage I non-small cell lung cancer (NSCLC) with passive scattering carbon-ion radiotherapy (C-ion RT) using daily computed tomography (CT) images. Materials and methods: We enrolled 10 patients with stage I NSCLC and acquired a total of 40 prefractional CT image series under the same settings as the planning CT images. These CT images were registered with planning CT images for dose evaluation using both bone matching (BM) and tumor matching (TM). Using deformable image registration, we generated accumulated doses. Moreover, the volumetric dose parameters were compared in terms of tumor coverage and lung exposure and statistical analyses were performed. Results: Overall, 25% of 40 fractional dose distributions were unacceptable with BM, compared with 2.5% with TM (P < 0.001). Using BM, three patients' accumulated dose distributions were unacceptable; however, all were satisfactory with TM (P < 0.001). No differences were observed in water-equivalent path length (WEL). The required margins in patients with poor dose distribution were 5.9 and 4.4 mm for BM and TM, respectively. Conclusions: This study establishes that CT image-based TM is robust compared with conventional BM for both daily and accumulated dose distributions. The effects of changes in WEL seem to be limited. Hence, daily CT alignment is recommended for patients with stage I NSCLC receiving C-ion RT. Ó 2020 The Author(s). Published by Elsevier B.V. Radiotherapy and Oncology 144 (2020) 224-230 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).For over two decades now, carbon-ion radiotherapy (C-ion RT) has been used for the treatment of early-stage non-small cell lung cancer (NSCLC) [1]. Compared with stereotactic body radiotherapy, which has exhibited promising outcomes for inoperable earlystage NSCLC [2], C-ion RT facilitates delivering a higher dose to the target with extremely low lung toxicity because of its fine dose concentration [3,4]. These advantages make C-ion RT a good treatment option for patients with NSCLC. However, C-ion RT is highly sensitive to anatomical changes that merit focus, especially for mobile tumors. Dose degradation caused by tumor movement is regarded as one of the potential factors for local recurrence in patients with NSCLC [5,6].The gated computed tomography (CT) and four-dimensional CT (4DCT) have been routinely used to manage the tumor motion [7]. The effects of respiratory motion are limited when an appropriate internal margin is applied [8]. However, the interfractional anatomical changes are the main source of the dose degradation in C-ion RT. Most published studies focus on their effects on the particle dose in a conventional treatment schedule (5-6 weeks) for patients with lung cancer using limited CT scans or 2D imaging technology [6,[9][10][11]. However, very few studies report hypofractionated C-ion RT. Recently, tumor displacement and changes in water-equival...